AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 APR 11 - (NewsRx.com & NewsRx.net) --
by N.R. Saltmarsh, staff medical writer - A mass vaccination program to address an upsurge of serogroup C meningococcal disease (SCMD) in Spain led to a decline of SCMD in both the vaccinated and general populations, according to a report in the Journal of Epidemiology and Community Health.
L. Salleras and colleagues evaluated a vaccination campaign directed toward the 18-month to 19-year-old age group in the last quarter of 1997. During this campaign, results were tracked via mandatory reporting and a national vaccine register.
At two years post-vaccination, the age-adjusted effectiveness of the vaccine was 94%, and only two of the 24 reported SCMD cases were among the vaccinated group, noted Salleras and team. This represented a reduction of more than two-thirds (68%) in the vaccinated population and 43% in the total population ("Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people," J Epidemiol Community Health, April 2001;55(4):283-7).
"Vaccination ...
Source: HighBeam Research, Mass Vaccination Program Dramatically Lowers Transmission In...